Skip to main content

Advertisement

Table 1 Comparison of baseline characteristics in case and control group

From: The antiretroviral efficacy of highly active antiretroviral therapy and plasma nevirapine concentrations in HIV-TB co-infected Indian patients receiving rifampicin based antituberculosis treatment

Variable HIV+TB
(Cases: N = 63)
HIV+
(Controls: N = 51)
P value
Age (years) Mean, IOR a 36.5 (24-60) 37.2 (25-57) 0.67
Gender
Males
Females
49 (77.7%)
14(22.22%)
36(70.6%)
15(29.4%)
0.38
Weight(Kg)
(Mean ± S.D.)
47.58 ± 7.78 51.47 ± 9.58 0.01
BMI (kg/m 2 )
(Mean + S.D.) b
17.83 ± 4.44 19.15 ± 4.67 0.20
CD4 cell count (cells/mm 3 )
(Median, IQR)
127 (16-693) 142 (9 -252) 0.36
Viral Load (copies/ml)
(Median, IQR)
161499
(129-6080000)
Not done -
Haemoglobin (g/dl),
(Mean + S.D.)
10.2 ± 2.08 11.5 ± 1.53 < 0.01
Bilirubin (mg/dl)
(Mean + S.D.)
0.63 ± 0.17 0.64 ± 0.21 0.93
AST (I.U)
(Mean + S.D.)
47.76 ± 39.37 38.79 ± 21.25 0.22
ALT (I.U.)
(Mean + S.D.)
37.33 ± 32.55 35.26 ± 19.84 0.74
Albumin (g/dl)
(Mean + S.D.)
3.72 ± 0.73 4.26 ± 0.57 < 0.001
  1. aInter Quartile Range
  2. bStandard deviation